drugset / Trial / NCT07585071
IASO206 in Patients With Relapsed/Refractory Autoimmune Hemolytic Anemia
NaSingle-groupOpen-labelTreatment
Summary
This study is an open-label, single-arm early exploratory clinical study, aiming to evaluate the safety, tolerability and preliminary efficacy of IASO206 Injection (In Vivo CAR-T) in Patients with Relapsed/Refractory Autoimmune Hemolytic Anemia
Timeline
- Start
- 2026-06-15
- Primary completion
- 2026-12-31
- Completion
- 2028-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | IASO206 | Unknown | 1e+08 unknown | — |
| Subject | IASO206 | Unknown | 3e+08 unknown | — |
| Subject | IASO206 | Unknown | 5e+08 unknown | — |